|
PRKDC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.237740E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.220300E-03 |
| Normal-vs-Stage2 |
2.759500E-02 |
| Normal-vs-Stage3 |
2.064900E-03 |
| Normal-vs-Stage4 |
1.864850E-03 |
| Stage1-vs-Stage2 |
9.367000E-01 |
| Stage1-vs-Stage3 |
6.203200E-01 |
| Stage1-vs-Stage4 |
5.144800E-01 |
| Stage2-vs-Stage3 |
6.876200E-01 |
| Stage2-vs-Stage4 |
5.611000E-01 |
| Stage3-vs-Stage4 |
7.984800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.902200E-03 |
| Normal-vs-AfricanAmerican |
2.919600E-01 |
| Normal-vs-Asian |
2.322500E-03 |
| Caucasian-vs-AfricanAmerican |
3.065800E-01 |
| Caucasian-vs-Asian |
4.891800E-01 |
| AfricanAmerican-vs-Asian |
1.422350E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.26219999999567E-05 |
| Normal-vs-Female |
5.820100E-03 |
| Male-vs-Female |
5.966200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.635100E-03 |
| Normal-vs-Age(41-60Yrs) |
3.638900E-04 |
| Normal-vs-Age(61-80Yrs) |
7.459800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.294400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.954400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.407000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.416400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.815000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.683200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.778200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.558000E-01 |
| Classical-VS-Follicular |
4.192900E-04 |
| Classical-VS-Other |
4.308400E-02 |
| Classical-VS-Normal |
2.644300E-02 |
| Tall-VS-Follicular |
1.604170E-01 |
| Tall-VS-Other |
1.121020E-01 |
| Tall-VS-Normal |
2.844000E-02 |
| Follicular-VS-Other |
4.078600E-01 |
| Follicular-VS-Normal |
1.78880999999187E-05 |
| Other-VS-Normal |
3.456000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.214400E-04 |
| Normal-vs-N1 |
5.570400E-04 |
| N0-vs-N1 |
3.818600E-01 |
|
|
